Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.02 (+0.20%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2025)

Drugs Made In America Acquisition (DMII) posted quarterly Non-Current Assets of $504.9 million for Q4 2025, up 643545.94% year-over-year from N/an in Q4 2024, and up 0.96% quarter-over-quarter from $500.1 million in Q3 2025.

Drugs Made In America Acquisition (DMII) Non-Current Assets (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Non-Current Assets for 2 consecutive years, with $504.9 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Non-Current Assets rose 643545.94% year-over-year to $504.9 million; the TTM figure through Dec 2025 stood at $504.9 million (up 643545.94% YoY), while the FY2025 annual figure was $504.9 million, up 643545.94% from the prior year.
  • Non-Current Assets improved to $504.9 million in Q4 2025 per DMII's latest filing, from $500.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $504.9 million in Q4 2025 and bottomed at $78449.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 260.52 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 245.51 Mn
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - 513.88 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 464.79 Mn
5 New Providence Acquisition Corp. III 401.18 Mn 401.18 Mn - 315.49 Mn
6 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 98.24 Mn
7 Aldel Financial 397.49 Mn 397.49 Mn - 247.40 Mn
8 Pioneer Acquisition I 390.89 Mn 653.32 Mn - 262.91 Mn
9 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 313.51 Mn
10 Gores Holdings X 385.06 Mn 384.87 Mn - 374.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 504.93 Mn
Sep 30, 2025 500.11 Mn
Dec 31, 2024 78,449.00